MPO-IN-1,99.02%
产品编号:Bellancom-139915| CAS NO:2471981-21-0| 分子式:C24H21ClN4| 分子量:400.90
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
MPO-IN-1
产品介绍 | MPO-IN-1 是一种有效的, 具有口服活性的,不可逆的含有吲哚结构的髓过氧化物酶 (MPO) 抑制剂,对 MPO 和甲状腺过氧化物 (TPO) 的 IC50 值分别为 2.6 μM 和 5.3 μM。MPO-IN-1 在急性炎症小鼠模型中抑制 MPO 活性。 | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | MPO-IN-1 is a potent, orally active, and irreversible indole-containing inhibitor of myeloperoxidase (MPO). MPO-IN-1 has IC50s of 2.6 μM and 5.3 μM for MPO and thyroid peroxidase (TPO), respectively. MPO-IN-1 inhibits MPO activity in an acute mouse model of inflammation. | ||||||||||||||||||||||
体外研究 | |||||||||||||||||||||||
体内研究 |
MPO-IN-1 (compound 2) (5 and 90 mg/kg; p.o.; four hours post-Zymosan A administration) significantly reduces MPO activity in a mouse peritonitis model of acute inflammation.
西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||
体内研究 |
MPO-IN-1 (compound 2) (5 and 90 mg/kg; p.o.; four hours post-Zymosan A administration) significantly reduces MPO activity in a mouse peritonitis model of acute inflammation.
西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||
性状 | Solid | ||||||||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 200 mg/mL (498.88 mM; ultrasonic and warming and heat to 60°C) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||
储存方式 |
| ||||||||||||||||||||||
参考文献 |